September 30, 2025Nanoscale AdvancesOpen Access

Retraction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model

View Full Paper

Ask AI

Bookmark

The study was aimed at enhancing therapeutic effects on liver cancer using DOX–AuGCs.
Results showed that DOX–AuGCs could improve treatment outcomes for liver cancer models.
The initial findings indicated a significant improvement in therapeutic effectiveness with the nanoparticles.
Retraction highlights the need for critical evaluation of published results in cancer therapy research.

No abstract yet

We only have this paper's title and publication details.

Retraction reports on enhancing therapeutic effect using gold complex nanoparticles in liver cancer.

No takes yet. Share an insight, caveat, or question.

Liu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark